The global demand for Swine Vaccines Market is presumed to reach the market size of nearly USD 3.44 Billion by 2032 from USD 2.12 Billion in 2023 with a CAGR of 5.52% under the study period 2024-2032.
Vaccines appear to induce protective immunity. It consists of antigens from viruses, bacterial toxins, bacteria, or parasites. Vaccines are injected into swine to accelerate an immune response, which will protect them against future infection with the organism. Swine vaccines can be live, containing living organisms that will multiply in the pig, or inactivated, consisting only killed organisms that will not multiply in the swine. Vaccines commonly used on pig includes E. coli diarrhea, clostridial dysentery of piglets, erysipelas, parvovirus infection, necrotic pleuropneumonia caused by Actinobacillus pleuropneumoniae, enzootic pneumonia caused by Mycoplasma hyopneumoniae, and atrophic rhinitis caused by toxigenic Pasteurella multocida.
An increase in pork consumption, escalating swine industry, and growing precautions taken to protect swine from epidemics and other threats drive the demand for swine vaccines worldwide. Rising pork consumption has given rise to a growing need to keep the swine free from every possible disease that could affect swine and threaten the human population. The growth of infection, epidemics, and intensive pig operations has made effective vaccination imperative in the swine industry. Outbreaks of diseases such as porcine respiratory and reproductive syndrome (PRRS) and porcine epidemic diarrhea have caused massive losses. These are controlled by vaccinating pregnant sows. There has also been growth in R&D expenditure for the innovation of unmet disease vaccines. However, high expenses of maintaining and handling storage conditions and the chance of a reverse reaction from vaccines are projected to impede the growth of global swine vaccines.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Swine Vaccines. The growth and trends of Swine Vaccines industry provide a holistic approach to this study.
This section of the Swine Vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
By Type
This section covers the regional outlook, which accentuates current and future demand for the Swine Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Swine Vaccines market include Merck & Co. Inc, Ceva, Zoetis, BoehringerIngelheim GmbH, Elanco, Indian. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1. PREFACE
1.1. Report Description
1.1.1 Objective
1.1.2 Target Audience
1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1 Market Research Process
1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3. SWINE VACCINES – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product
3.7.2 Market Attractiveness Analysis By Type
3.7.3 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL SWINE VACCINES MARKET ANALYSIS BY PRODUCT
5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Attenuated Live Vaccines Historic and Forecast Sales By Regions
5.5. Inactivated Vaccines Historic and Forecast Sales By Regions
5.6. Subunit Vaccines Historic and Forecast Sales By Regions
5.7. DNA Vaccines Historic and Forecast Sales By Regions
5.8. Recombinant Vaccines Historic and Forecast Sales By Regions
6. GLOBAL SWINE VACCINES MARKET ANALYSIS BY TYPE
6.1. Overview By Type
6.2. Historical and Forecast Data
6.3. Analysis By Type
6.4. Swine Influenza Historic and Forecast Sales By Regions
6.5. Classical Swine Fever Historic and Forecast Sales By Regions
6.6. Porcine Parvovirus ...
Avail customized purchase options to meet your exact research needs: